Candida albicans responses to antifungals and cell wall stress

白色念珠菌对抗真菌药物和细胞壁应激的反应

基本信息

  • 批准号:
    8824827
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2018-09-30
  • 项目状态:
    已结题

项目摘要

Candidemia, the fourth most common bloodstream infection in the U.S., and other forms of systemic candidiasis are associated with mortality rates of 40% or more despite treatment with antifungal agents. The Candida albicans cell wall is central to the pathogenesis of candidiasis, but mechanisms that link cell wall regulation and virulence are only beginning to be understood. Recently, we demonstrated that C. albicans rapidly delocalizes phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) and septins as part of the natural response to the cell wall-active antifungal caspofungin. Furthermore, we identified a novel C. albicans PI(4,5)P2-septin pathway that regulates cell wall integrity and virulence among mice with candidiasis. We hypothesize that the ability to activate or down-regulate the PI(4,5)P2-septin pathway as dictated by the environment (i.e., balanced regulation) is necessary for optimal C. albicans responses to cell wall stress during drug exposure or invasive candidiasis. The objectives of this project are to prove our balanced regulation hypothesis, validate the proposed PI(4,5)P2-septin pathway, and identify its outputs. We will pursue three specific aims. The first aim is to demonstrate that balanced PI(4,5)P2 regulation correlates with protective responses to caspofungin. Dynamic PI(4,5)P2 responses will be correlated with cellular viability in PI(4,5)P2- regulatory mutants and caspofungin-susceptible and -resistant C. albicans strains. The second aim is to establish interactions between PI(4,5)P2 and other PI(4,5)P2-septin pathway components during caspofungin exposure and invasive candidiasis. Interactions will be assessed by tracking components during time-lapse live cell imaging, demonstrating physical interactions, and visualizing interactions within cells by fluorescence resonance energy transfer (FRET). PI(4,5)P2 levels in pathway mutants will be directly correlated with PKC- MAPK cell wall integrity pathway activation. The third aim is to link transcription factors to the PI(4,5)P2-septin pathway, and identify transcriptional outputs and pathway targets that contribute to caspofungin responses and pathogenesis. Transcriptional outputs will be defined during intra-abdominal candidiasis of mice by using RNA-Seq, a largely unbiased method that comprehensively quantitates gene expression. The project employs a series of innovative techniques to study a novel pathway that is relevant to antifungal drug resistance and the pathogenesis of candidiasis. Therefore, it is likely to yield clinically useful insights that would not be obtained through other studies. Our findings will be significant because they will explain how the PI(4,5)P2-septin pathway governs cell wall integrity, echinocandin susceptibility and resistance, and pathogenesis, and place the pathway within the context of other regulators of these processes. The project will open new avenues of investigation that will define, in detail, the molecular and cellular mechanisms by which the PI(4,5)P2-septin pathway contributes to diverse types of candidiasis, and the impact of cell wall regulation on interactions with the host.
念珠菌病是美国第四大最常见的血液感染,以及其他形式的系统性感染

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CORNELIUS J CLANCY其他文献

CORNELIUS J CLANCY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CORNELIUS J CLANCY', 18)}}的其他基金

Polyclonality of carbapenem resistant Enterobacteriaceae bloodstream infections
碳青霉烯类耐药肠杆菌科细菌血流感染的多克隆性
  • 批准号:
    10301365
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Microbiome and host response signatures for pneumonia among lung transplant recipients
肺移植受者肺炎的微生物组和宿主反应特征
  • 批准号:
    9168095
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    10412906
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Evolution of KPC-K pneumoniae that persist in patients on prolonged antibiotics
长期服用抗生素的患者体内持续存在的 KPC-K 肺炎的演变
  • 批准号:
    8823883
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    10043819
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    8974303
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    9666582
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    8633820
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Candida albicans responses to antifungals and cell wall stress
白色念珠菌对抗真菌药物和细胞壁应激的反应
  • 批准号:
    10515350
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
The candida albicans cell wall regulatory network and pathogenesis
白色念珠菌细胞壁调控网络和发病机制
  • 批准号:
    8112208
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了